Access the most updated information regarding COVID-19 and inherited bleeding disorders: www.hemophilia.ca/covid-19
WFH Advisory: availability of desmopressin pending re-start of intranasal desmopressin manufacture
It is an exciting time in the treatment of people with bleeding disorders with many coagulation products having been recently approved by Health Canada or...
www.hemophilia.ca/coagulation-products
The World Federation of Hemophilia (WFH) has published the 3rd Edition of the Guidelines for the Management of Hemophilia, replacing the 2nd Edition published in...
